Weight loss plateaus are one of the most common reasons patients become discouraged with GLP-1 therapy. In this article, we discuss how plateaus are a normal part of the GLP-1 therapy process and reflect natural physiological adaptation rather than treatment failure....
Key Takeaways Losing inches but not weight may reflect body recomposition, where fat loss occurs while muscle is maintained or gained. The scale measures total body weight, but it does not show how much of that weight is fat, muscle, or water. Measurements, clothing...
Key Takeaways GLP-1 microdosing generally refers to a lower-dose semaglutide approach used under medical supervision. Some patients are interested in low dose semaglutide to support appetite regulation, reduce food noise, and help maintain weight loss. Maintenance...
Losing weight can be transformative for your health, confidence, and overall well-being. However, many people are surprised to find that, while their bodies feel lighter and healthier, their faces may appear more tired, hollow, or older than expected. Discover why...
As more patients use GLP-1 medications like semaglutide and tirzepatide for weight management, it is common to notice changes that go beyond weight alone, particularly in the face. One term you may have come across is “Ozempic face.” While the name can sound...
